Fig. 3From: Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE−/− MiceHyperglycemia impaired efferocytosis while MerTK expression reduction. A RT‐qPCR analysis of Mertk mRNA levels in RAW 264.7 and BMDMs treated as indicated. B Western blot analysis of MerTK expression in RAW 264.7 and BMDMs treated as indicated. Data are presented as mean ± SEM of three independent experiments. Statistical significance was determined by student’s t test, *P < 0.05Back to article page